Trans-3-aza-bicyclo[3.1.0]hexane derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S452000, C548S465000, C548S467000

Reexamination Certificate

active

08063099

ABSTRACT:
The invention relates to novel trans-3-aza-bicyclo[3.1.0]hexane derivatives of formula (I), wherein A, B, n and R1are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.

REFERENCES:
patent: 2006/0040937 (2006-02-01), Branch et al.
patent: WO 01/96302 (2001-12-01), None
patent: WO 02/44172 (2002-06-01), None
patent: WO 02/090355 (2002-11-01), None
patent: WO 03/041711 (2003-05-01), None
patent: WO 03/051368 (2003-06-01), None
patent: WO 03051368 (2003-06-01), None
patent: WO 2004/026866 (2004-04-01), None
patent: WO 2006/011042 (2006-02-01), None
patent: WO 2008/038251 (2008-04-01), None
patent: WO 2008038251 (2008-04-01), None
patent: WO 2008/150364 (2008-12-01), None
Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 2050-2057.
Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 1992-1996.
FDA mulls drug to slow late-stage Alzheimer's [online], [retrieved on Sep. 23, 2003]. Retrieved from the Internet, URL; http://www.cnn.com/2003/HEALTH/conditions/O9/24/alzheimers.drug.ap/indexhtml>.
Dementia [online], [retrieved on May 24, 2007]. Retrieved from the Internet, URL; http:llen.wikipedia.orglwikilDementia>.
Cai, et al., Antagonists of the Orexin Receptors, Expert Opinion on the Therapeutic Patents, Informa Healthcare, GB, vol. 16, No. 5, May 1, 2006, pp. 631-646.
U.S. Appl. No. 12/521,453, filed Jun. 29, 2009, Aissaoui, et al.
U.S. Appl. No. 12/311,451, filed Mar. 27, 2009, Aissaoul, et al.
Andreani, A., et al., Eur. J. Med. Chem., vol. 17, pp. 271-274, (1982).
Berry, C.R., et al., Cycloaddition Reactions of Thiazolium Azomethine Ylides: Application to Pyrrolo[2,1-b]thiazoles, Organic Letters, vol. 9, No. 21, pp. 4099-4102, (2007).
Cai, J., et al. Antagonists of the Orexin Receptors, Expert Opinion on Therapeutic Patents, Informa Healthcare, GB, vol. 16, No. 5, pp. 631-646, (May 1, 2006).
Chemelli, R.M., Narcolepsy in orexin Knock Out Mice: Molecular Genetics of Sleep Regulation, Cell, Aug. 20, 1999, vol. 98, 437-451, Cell Press.
Eissenstat, M.A., Aminoalkylindoles: Structure-Activity Relationships of Novel Cannabinoid Mimetics, Journal of Medicinal Chemistry, 1995, vol. 38, 3094-3105, American Chemical Society, Washington DC, USA.
Gould, P.L., Salt Selection for Basic Drugs, International Journal of Pharmaceutics, 1986, vol. 33, 201-217.
Madalengoitia, J. S., et al., Cyclopropanation Reactions of Pyroglutamic Acid-Derived Synthons with Akylidene Transfer Reagents, J. Org. Chem. vol. 64, pp. 547-555, (1999).
March, J., et al., Advanced Organic Chemistry, 4thEdition, John Wiley & Sons, pp. 447-449, 491-493, 919-920, 931, and 1167-1171, (1992).
Reisch, J., et al., Synthesis of Daurine and Folidine: Two 2(1H)-Quinolinone Aldaloids from Haplophyllum Species, Monatshefte für Chemie, vol. 119, pp. 1169-1178, (1988).
Remington, The Science and Practice of Pharmacy, 21stEdition (2005), Part 5, “Pharmaceutical Manufacturing”, [published by Lippincott Williams & Wilkins].
Sakurai, T. et al., Orexin & Orexin Receptors: A Family of Hypothalamic Neuropeptides and GProtein-Couples Receptors that Regulate Feeding Behavior, Cell, Feb. 20, 1998, vol. 92, 573-585, Cell Press.
Koberstein, R., et al., Tetrahydroisoquinolines as Orexin Receptor Antgonists, Chimia, 2003, vol. 57, No. 5, pp. 270-275.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Trans-3-aza-bicyclo[3.1.0]hexane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Trans-3-aza-bicyclo[3.1.0]hexane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trans-3-aza-bicyclo[3.1.0]hexane derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4297094

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.